Sonodynamic Therapy Complements PD-L1 Immune Checkpoint Inhibition in a Murine Model of Pancreatic Cancer

被引：0
|
作者：
Nesbitt, Heather [1 ]
Logan, Keiran [1 ]
Thomas, Keith [1 ]
Callan, Bridgeen [1 ]
Gao, Jinhui [1 ]
Mc Kaig, Thomas [1 ]
Taylor, Mark [2 ]
Love, Mark [3 ]
Stride, Eleanor [4 ]
Mc Hale, Anthony [1 ]
Callan, John [1 ]
机构：
[1] Ulster Univ, Coleraine, Londonderry, North Ireland
[2] Mater Hosp, Belfast, Antrim, North Ireland
[3] Royal Victoria Hosp, Belfast, Antrim, North Ireland
[4] Univ Oxford, Oxford, England
来源：
BRITISH JOURNAL OF SURGERY | 2021年 / 108卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
O-P04
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Acral Necrosis After PD-L1 Immune Checkpoint Inhibitor Therapy
    Logan, Sam
    Shinohara, Michi M.
    CUTIS, 2023, 111 (05): : E16 - E17
  • [22] Optimizing Sequence of PD-L1 Immune-Checkpoint Inhibitors and Radiation Therapy in Bladder Cancer
    Tholomier, Come
    Marcq, Gautier
    Shinde-Jadhav, Surashri
    Ayoub, Mina
    Huang, Jia Min
    Kool, Ronald
    Skowronski, Rodrigo
    Brimo, Fadi
    Mansure, Jose Joao
    Kassouf, Wassim
    BLADDER CANCER, 2020, 6 (03) : 295 - 302
  • [23] PD-L1 inhibition improves response of pancreatic cancer to radiotherapy
    Azad, A.
    D'Costa, Z.
    Lim, S. Y.
    Sansom, O.
    McKenna, W. G.
    Muschel, R.
    Fokas, E.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S133 - S133
  • [24] Repurposing pentamidine for cancer immunotherapy by targeting the PD1/PD-L1 immune checkpoint
    Gu, Tingxuan
    Tian, Xueli
    Wang, Yuanyuan
    Yang, Wenqian
    Li, Wenwen
    Song, Mengqiu
    Zhao, Ran
    Wang, Mengqiao
    Gao, Quanli
    Li, Tiepeng
    Zhang, Chengjuan
    Kundu, Joydeb Kumar
    Liu, Kangdong
    Dong, Zigang
    Lee, Mee-Hyun
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [25] Prospective role of PD-1/PD-L1 immune checkpoint inhibitors in GI cancer
    AmeliMojarad, Mandana
    AmeliMojarad, Melika
    Cui, Xiaonan
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 244
  • [26] PD-1/PD-L1 immune checkpoint blockade in ovarian cancer: Dilemmas and opportunities
    Peng, Zikun
    Li, Ming
    Li, Huayi
    Gao, Qinglei
    DRUG DISCOVERY TODAY, 2023, 28 (08)
  • [27] PARP and PD-1/PD-L1 checkpoint inhibition in recurrent or metastatic endometrial cancer
    Post, Cathalijne C. B.
    Westermann, Anneke M.
    Bosse, Tjalling
    Creutzberg, Carien L.
    Kroep, Judith R.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2020, 152
  • [28] Structural basis of PD-1/PD-L1 checkpoint inhibition
    Magiera, K.
    Zak, K.
    Berlicki, L.
    Domling, A.
    Holak, T.
    Dubin, G.
    FEBS JOURNAL, 2017, 284 : 45 - 45
  • [29] Impact of radio(chemo)therapy on expression of immune checkpoint ligands PD-L1 and PD-L2 on murine and human melanoma cells
    Riegel, D.
    Baeumler, M.
    Spiljar, M.
    Rueckert, M.
    Frey, B.
    Fietkau, R.
    Derer, A.
    Gaipl, U. S.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S132 - S132
  • [30] SPECT/CTimaging of the PD-1/PD-L1 immune checkpoint pathway in syngeneic murine tumor models
    Heskamp, S.
    Molkenboer-Kuenen, J. D. M.
    van de Vondervoort, R. H. A. M.
    Boerman, O. C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S147 - S147
12345